[Sulfonylureas and diabetes mellitus]

LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study.

International journal of cardiology·2018

Gene expression profile following an oral unsaturated fat load in abdominal obese subjects.

European journal of nutrition·2018

Old and new basal insulin formulations: understanding pharmacodynamics is still relevant in clinical practice.

Diabetes, obesity & metabolism·2014

Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population.

International journal of clinical practice·2012

AT1 Receptor Gene Polymorphisms in relation to Postprandial Lipemia.

International journal of vascular medicine·2011

Plasma homocysteine levels are associated with ulceration of the foot in patients with type 2 diabetes mellitus.

Diabetes/metabolism research and reviews·2010

Optimising the duration of antimicrobial treatment in the era of Antimicrobial Stewardship Programs.

Medicina clinica·2026

Reduced serum IL-6 as a potential peripheral marker of amnestic mild cognitive impairment: A pilot study.

Medicina clinica·2026

Foundations for the rational prescription of enteral medical nutrition therapy.

Medicina clinica·2026

Ambient AI scribe in pediatric outpatient visits: documentation burden, quality, and scale-up limits.

Medicina clinica·2026

Eating disorders.

Medicina clinica·2026

Tobacco-related and tobacco-attributable cancer mortality in Spain, 1999-2023: trends and gender inequalities.

Medicina clinica·2026

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Cureus·2026

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Frontiers in endocrinology·2026

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Canadian journal of kidney health and disease·2026

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Frontiers in pharmacology·2026

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Frontiers in molecular neuroscience·2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Therapeutic advances in neurological disorders·2026

Related Experiment Videos

[Sulfonylureas and diabetes mellitus]

Related Concept Videos

LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study.

Gene expression profile following an oral unsaturated fat load in abdominal obese subjects.

Old and new basal insulin formulations: understanding pharmacodynamics is still relevant in clinical practice.

Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population.

AT1 Receptor Gene Polymorphisms in relation to Postprandial Lipemia.

Plasma homocysteine levels are associated with ulceration of the foot in patients with type 2 diabetes mellitus.

Optimising the duration of antimicrobial treatment in the era of Antimicrobial Stewardship Programs.

Reduced serum IL-6 as a potential peripheral marker of amnestic mild cognitive impairment: A pilot study.

Foundations for the rational prescription of enteral medical nutrition therapy.

Ambient AI scribe in pediatric outpatient visits: documentation burden, quality, and scale-up limits.

Eating disorders.

Tobacco-related and tobacco-attributable cancer mortality in Spain, 1999-2023: trends and gender inequalities.

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Related Experiment Videos

[Sulfonylureas and diabetes mellitus]

Related Concept Videos

Related Articles